What's new in psoriasis? An analysis of guidelines and systematic reviews published in 2009-2010Citation formats

Standard

What's new in psoriasis? An analysis of guidelines and systematic reviews published in 2009-2010. / Foulkes, A. C.; Grindlay, D. J C; Griffiths, C. E M; Warren, R. B.

In: Clinical and Experimental Dermatology, Vol. 36, No. 6, 08.2011, p. 585-588.

Research output: Contribution to journalArticle

Harvard

APA

Vancouver

Author

Foulkes, A. C. ; Grindlay, D. J C ; Griffiths, C. E M ; Warren, R. B. / What's new in psoriasis? An analysis of guidelines and systematic reviews published in 2009-2010. In: Clinical and Experimental Dermatology. 2011 ; Vol. 36, No. 6. pp. 585-588.

Bibtex

@article{f61b0d63888b42f7ae37ca28f88a19f7,
title = "What's new in psoriasis? An analysis of guidelines and systematic reviews published in 2009-2010",
abstract = "This review summarizes key clinical findings from 5 guidelines and 21 systematic reviews on psoriasis published or indexed in the period November 2009 to October 2010. The highlights include the British Association of Dermatologists guidelines on the use of biological interventions in psoriasis, and guidelines on the efficacy and use of acitretin. Biological therapies were reviewed for use in specific patient groups (such as those with hepatitis C) and from a health-economics perspective. Another systematic review focused on outcome measures used to assess the severity of psoriasis. Finally, comorbidities including cardiovascular risk were the topic of four systematic reviews. Click for the corresponding questions to this CME article. {\circledC} 2011 British Association of Dermatologists.",
author = "Foulkes, {A. C.} and Grindlay, {D. J C} and Griffiths, {C. E M} and Warren, {R. B.}",
note = "G1000417, Medical Research Council, United Kingdom, Medical Research Council, United Kingdom",
year = "2011",
month = "8",
doi = "10.1111/j.1365-2230.2011.04108.x",
language = "English",
volume = "36",
pages = "585--588",
journal = "Clinical and Experimental Dermatology",
issn = "0307-6938",
publisher = "John Wiley & Sons Ltd",
number = "6",

}

RIS

TY - JOUR

T1 - What's new in psoriasis? An analysis of guidelines and systematic reviews published in 2009-2010

AU - Foulkes, A. C.

AU - Grindlay, D. J C

AU - Griffiths, C. E M

AU - Warren, R. B.

N1 - G1000417, Medical Research Council, United Kingdom, Medical Research Council, United Kingdom

PY - 2011/8

Y1 - 2011/8

N2 - This review summarizes key clinical findings from 5 guidelines and 21 systematic reviews on psoriasis published or indexed in the period November 2009 to October 2010. The highlights include the British Association of Dermatologists guidelines on the use of biological interventions in psoriasis, and guidelines on the efficacy and use of acitretin. Biological therapies were reviewed for use in specific patient groups (such as those with hepatitis C) and from a health-economics perspective. Another systematic review focused on outcome measures used to assess the severity of psoriasis. Finally, comorbidities including cardiovascular risk were the topic of four systematic reviews. Click for the corresponding questions to this CME article. © 2011 British Association of Dermatologists.

AB - This review summarizes key clinical findings from 5 guidelines and 21 systematic reviews on psoriasis published or indexed in the period November 2009 to October 2010. The highlights include the British Association of Dermatologists guidelines on the use of biological interventions in psoriasis, and guidelines on the efficacy and use of acitretin. Biological therapies were reviewed for use in specific patient groups (such as those with hepatitis C) and from a health-economics perspective. Another systematic review focused on outcome measures used to assess the severity of psoriasis. Finally, comorbidities including cardiovascular risk were the topic of four systematic reviews. Click for the corresponding questions to this CME article. © 2011 British Association of Dermatologists.

U2 - 10.1111/j.1365-2230.2011.04108.x

DO - 10.1111/j.1365-2230.2011.04108.x

M3 - Article

VL - 36

SP - 585

EP - 588

JO - Clinical and Experimental Dermatology

JF - Clinical and Experimental Dermatology

SN - 0307-6938

IS - 6

ER -